Elizabeth Kwo

Board Director

Director

Flexion Therapeutics Inc Asensus Surgical, Inc.Kestra Medical Technologies, Ltd.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€8,734

▼ Sales (1 ops.)

€85k

Latest filing published 23 Sept 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €85k. Read the official filing

Filing timeline

BuySale

Elizabeth Kwo

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Elizabeth Kwo: trading record in brief

Elizabeth Kwo (board member) discloses dealings in 3 companies, chiefly Asensus Surgical, Inc., Kestra Medical Technologies, Ltd. and Flexion Therapeutics Inc. In total, 9 filings cover trades dated from 24 June 2021 to 21 September 2026.

Both buying and selling appear: 1 purchase worth €8,734, against 1 sale worth €85k. Netting one side against the other leaves €76k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 23 September 2026: an open-market sale of €85k, in Kestra Medical Technologies, Ltd. The most recent open-market purchase was published on 16 March 2022, 1,677 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.